ArticleJournal of clinical microbiology2004

Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients.

Wendell S F Meira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.